An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00949910 · COMPLETED

Trial details

NCT number: NCT00949910
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2004-11-01
Primary completion: 2009-04-01
Enrollment: 6586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.